Publications
February 27, 2019 Article

Environmental Alert: EPA Announces New Pharmaceutical Waste Standards for Healthcare Facilities

Environmental Alert

The U.S. Environmental Protection Agency (EPA) recently promulgated new rules regarding management of unused, unwanted or expired pharmaceuticals that are regulated as hazardous waste.  The rules, promulgated under the Resource Conservation and Recovery Act (RCRA), impact a broad range of healthcare facilities, including hospitals, physicians’ and dentists’ offices, and retail pharmacies, as well as manufacturers that are “reverse distributors” of pharmaceuticals.

Compliance with RCRA requirements has been a challenge for healthcare facility personnel, who, unlike industrial manufacturing facility staff, are primarily focused on providing care for patients and generally do not have the expertise to make hazardous waste determinations for the wide variety of pharmaceuticals generated in small quantities across any given facility.

EPA’s goals in issuing the new rule are to protect waterways and wastewater treatment systems by preventing pharmaceuticals from being “drain disposed” and to improve management of unused and expired pharmaceuticals that are reverse distributed (i.e., returned) to manufacturers.

Key aspects of the new rule are as follows:

  • Healthcare facilities that generate more than 100 kg (220 lbs) of hazardous waste or 1 kg (2.2 lbs) of acute hazardous waste per month are subject to the new regulations.  Those facilities generating below these threshold amounts are categorized as “very small quantity generators” (VSQGs) and are largely exempt from the new rule but must comply with certain limited requirements.
  • Healthcare facilities subject to the rule will no longer be required to maintain central hazardous waste storage facilities and will be able to store expired pharmaceuticals up to one year (rather than just 90 days).
  • All healthcare facilities (including VSQGs) are prohibited from “sewering” or “flushing” waste pharmaceuticals and are also subject to new “empty container” standards.
  • VSQGs may take advantage of less onerous off-site disposal standards, provided they meet certain conditions.
  • While prescription pharmaceuticals are still defined as regulated waste when sent to a reverse distribution center, over-the-counter (OTC) pharmaceuticals are exempt from the new rule so long as there is a “reasonable expectation” they will be “legitimately used/reused or reclaimed when sent to such a center.”  While facilities must still make a judgment call as to what may be sent to a reverse logistics center, EPA clarifies in guidance that unsold non-prescription pharmaceuticals where the outer packaging is damaged, but the inner container remains intact with no leaks, would not be considered a waste.
  • In response to a long-standing request from retailers, OTC nicotine replacement therapies (patches, gums, and lozenges, but not e-cigarettes) are specifically excluded from regulation as hazardous waste. 

The federal rules become effective on August 21, 2019.  However, states that are authorized to administer their own RCRA programs (e.g., all of the New England states), may have more stringent state rules governing pharmaceutical wastes on the books.  Until such state rules are brought in line with the new federal approach, healthcare facilities should proceed cautiously in amending their waste pharmaceutical management practices.

Firm Highlights

News

David Van Slyke Reappointed by Governor Mills to New England Interstate Water Pollution Control Commission

Van Slyke is one of five Commissioners from the state of Maine overseeing NEIWPCC PORTLAND—Preti Flaherty’s Managing Partner, David Van Slyke, has been reappointed by Governor Janet T. Mills to the New England Interstate...

Publication

How Much Permitting "Reform" Comes from the New Debt Ceiling Legislation?

Without fanfare or ceremony, on Saturday June 3 rd , President Biden signed the bitterly-negotiated Fiscal Responsibility Act of 2023 (FRA), also known as the Debt Ceiling Limit legislation. While most of the media...

News

David Van Slyke Named to 2024 Lawdragon Green 500: Leaders in Environmental Law

Preti Flaherty’s Managing Partner David Van Slyke has been recognized by Lawdragon as one of the top 500 environmental lawyers in the U.S. It’s the third time he has been named to this prestigious...

Publication

Post Sackett: What Is the Scope of the Clean Water Act?

The Supreme Court of the United States (SCOTUS) rendered a decision in Sackett et ux. v. EPA addressing what Justice Alito referred to as a “nagging question” of what water bodies are covered under...

News

Preti Flaherty Welcomes Attorneys Michelle Amidzich Fritz and Kat Mail to the Firm

Preti Flaherty is pleased to announce the arrival of attorneys Michelle Amidzich Fritz and Kat Mail. Michelle Amidizich Fritz joins the firm’s Environmental Practice Group in the Boston office. She is a graduate of...